Stanniocalcin-1 and Tumor Angiogenesis in Gastric Cancer
Author Information
Author(s): He Ling-fang, Wang Ting-ting, Gao Qian-ying, Zhao Guang-feng, Huang Ya-hong, Yu Li-ke, Hou Ya-yi
Primary Institution: Nanjing University
Hypothesis
Stanniocalcin-1 promotes angiogenesis and tumor growth through the up-regulation of VEGF in gastric cancer cells.
Conclusion
Stanniocalcin-1 enhances VEGF expression, which promotes tumor angiogenesis and growth in gastric cancer.
Supporting Evidence
- STC-1 was found to promote angiogenesis in both in vitro and in vivo experiments.
- Inhibition of VEGF expression abolished STC-1 induced angiogenesis.
- The study identified PKCĪ²II and ERK1/2 as key pathways mediating STC-1's effects on VEGF expression.
Takeaway
Stanniocalcin-1 helps tumors grow by making new blood vessels, and it does this by increasing a substance called VEGF.
Methodology
The study used BGC/STC and BGC/shSTC cell lines to investigate the effects of STC-1 on tumor growth and angiogenesis in vitro and in vivo, employing ELISA and western blot techniques.
Potential Biases
Potential bias in the selection of cell lines and experimental conditions.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully replicate human gastric cancer conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website